Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026
Facebook X (Twitter) Instagram
Trending
  • Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening
  • Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence
  • Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation
  • Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand
  • From the Mountains to the Sea: Captain Sanjay’s Initiative Opens New Career Opportunities for Himachal’s Daughters in the Merchant Navy
  • Shanti Educational Initiatives Wins BSE Clearance for Merger With Solar Powerhouse GREW Energy
  • How IH Global Helps Businesses Build Powerful Brand Experiences Through Exhibition Design, Trade Shows and Experiential Technology
  • How to Choose Furniture That Complements Your Lifestyle and Living Space
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Press Release»IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India
Press Release

IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India

Arjun SinghBy Arjun SinghAugust 17, 2024No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Mumbai (Maharashtra) [India], August 16: As per the ICMR-INDIAB (2023) study, 10 crore people in India suffer from diabetes, with an additional 13.6 crore people affected by pre-diabetes. This significant health concern positions India to become the diabetes capital of the world by 2030.

In response to this serious healthcare challenge, IPCA Laboratories Ltd proudly announces the launch of Diulcus, a novel product aimed at addressing the challenges of Diabetic Foot Ulcer (DFU) in the Indian market. Diulcus, developed by NovaLead Pharma Pvt Ltd, a pioneer in drug repurposing, represents a significant advancement in the management of DFU. The product has received approval from the Central Drugs Standard Control Organization (CDSCO) and was partially funded by the Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise.

The launch event was graced by esteemed personalities, including Sri. Premchand Godha, Sri AK Jain, Dr. Anil Pareek, Sri Sunil Ghai, and Sri. Supreet Deshpande.

During phase 3 trials in India, Diulcus demonstrated remarkable efficacy, with a 60.3% ulcer closure rate within three months of treatment. Remarkably, patients continued to show an ulcer closure rate of 77.20% over six months, even after stopping treatment at three months. These results are among the best observed for any pharmaceutical preparation used in DFU treatment.

Mr. Premchand Godha, Executive Chairman of IPCA Laboratories Ltd, expressed his enthusiasm about the launch, stating, “With over 15% of diabetic patients suffering from DFU at least once in their lifetime, DFU is the most prevalent complication caused by chronic diabetes. The approval of this patented repurposed drug is significant because DFU is the leading cause for lower limb amputations globally. We are delighted to partner with NovaLead Pharma Pvt Ltd through an IP licensing arrangement to bring Diulcus® for DFU patients in India. It demonstrates IPCA’s commitment towards the patients suffering from unmet medical need and its focus on the diabetes therapy.”

Diulcus will be made available to the patients of DFU by Ipca Laboratories Ltd. (Ipca) through an exclusive IP licensing arrangement with NovaLead for Indian starting August 2024.

Disclaimer: The article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

PR press-release
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

Best Crypto Presale 2026: AlphaPepe Triggers Buying Surge with Up to 200% Bonus Drop as Bitcoin Eyes $100K

September 1, 2026

Resilience Actions, a Re Sustainability Initiative, Launches ECOHUB.IN to Power India’s Climate and Circular Economy Innovation Ecosystem

July 3, 2026

Social Activist Shanaya Sharma Honored with Prestigious Nari Astitva Award 2026

March 10, 2026

Comments are closed.

Top Posts

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
Lifestyle

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

By Arjun SinghNovember 20, 2026

New Delhi [India], November 20: Braces are no longer just for teenagers. Across Hyderabad, students,…

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026

Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand

November 20, 2026
Most Popular

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026

Type above and press Enter to search. Press Esc to cancel.